Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

JCR Pharmaceuticals Co. Ltd.

www.jcrpharm.co.jp

Latest From JCR Pharmaceuticals Co. Ltd.

Cell Therapies Forge Ahead In Japan with Reimbursement, Approval Decisions

A controversial cell therapy for spinal injuries receives coverage under Japan’s national health scheme, amid signs that the pricing of regenerative therapies may come under more scrutiny, while the first CAR-T treatment in the country takes a step closer to market.

Japan Approvals

Rohto’s Cirrhosis Cell Therapy Finds Japan Partner In Shionogi

In a sign of continued corporate interest in the regenerative and cell therapy area in Japan, Shionogi has acquired rights in this market to a novel cirrhosis treatment being developed by Rohto.

Japan Commercial

SCM Lifescience CEO On Developing High Purity, Disease-Specific Stem Cell Therapies

Emerging Company Profile: Capitalizing on its proprietary platform technologies designed to develop high efficacy, disease-specific and low cost stem cell products, South Korea's SCM Lifescience aims to prove in clinical trials how its product candidates differ from existing stem cell therapies.

StartUps and SMEs South Korea

Pipeline Watch: Phase III Progress With BL-8040, Recorlev And Estelle

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

 

Pipeline Watch Approvals
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Medical Devices
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • JCR Pharmaceuticals Co. Ltd.
  • Senior Management
  • Shin Ashida, Pres. & CEO
    Teiji Tomio, Dir., Clin. Dev. & R&D
  • Contact Info
  • JCR Pharmaceuticals Co. Ltd.
    Phone: (81) 797 32 8591
    3-19 Kasuga-Cho
    Ashiya City, 659-0021
    Japan
Advertisement
Advertisement
UsernamePublicRestriction

Register